Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Rev Chir Orthop Reparatrice Appar Mot ; 94(4 Suppl): S22-35, 2008 Jun.
Artículo en Francés | MEDLINE | ID: mdl-18513574

RESUMEN

Thoracolumbar fractures are frequent and the functional outcomes are sometimes severe. This multicentric study, including five medical centers, was performed to evaluate the long-term outcomes of the patients. One hundred and thirty six patients with thoracolumbar fracture (T11 to L2) was evaluated with a minimal follow-up of two years. Every one had a clinical exam with a score of Oswestry and an X-Ray study (before and after treatment and at revision). Most of them presented compression fractures, the most often at L1 level. On X-rays, a gain was noted on the vertebral kyphosis immediately after surgery, but there is a loss of correction over time whatever the treatment. The clinical outcomes for the patients were great, with an Oswestry average score of 6,4. A correlation was noted between this functional score and vertebral kyphosis. So, an anterior column strengthening (isolated or performed during the surgery) could improve these functional outcomes. Moreover, the Thoraco Lumbar Injury Severity Score (TLISS) seems to be a simple organigram to determine the most appropriate treatment of these fractures, with particular attention to the distraction mechanism or posterior ligamentous complex lesions. However, RMI before surgery is necessary to evaluate these lesions.


Asunto(s)
Fijación Interna de Fracturas , Vértebras Lumbares/lesiones , Fracturas de la Columna Vertebral , Fusión Vertebral , Vértebras Torácicas/lesiones , Adulto , Femenino , Fijación Interna de Fracturas/instrumentación , Fijación Interna de Fracturas/métodos , Humanos , Fijadores Internos , Vértebras Lumbares/cirugía , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Radiografía , Fracturas de la Columna Vertebral/clasificación , Fracturas de la Columna Vertebral/diagnóstico , Fracturas de la Columna Vertebral/diagnóstico por imagen , Fracturas de la Columna Vertebral/fisiopatología , Fracturas de la Columna Vertebral/cirugía , Vértebras Torácicas/cirugía , Resultado del Tratamiento
2.
Rev Chir Orthop Reparatrice Appar Mot ; 94(4 Suppl): S2-21, 2008 Jun.
Artículo en Francés | MEDLINE | ID: mdl-18513573

RESUMEN

The tibial valgus osteotomy whatever its technique has a survival rate of about 85 % to 10 years, if we consider the reoperation as a criterion of failure, with a confidence index at 78%. The age, weight, sex and functional signs have no impact on the outcome. We have found no evidence in the preoperative radiographic assessment, neither the medial pinch, or varus epiphyseal neither varisant gap, which could be a failure and a reoperation before the tenth year. Good results were observed significantly when there is an over-valgus at least 3 degrees of global axis of the lower limb. This corresponds to a valgus epiphyseal by more than 2 degrees . The substantial reduction in the gap varisant that lowers the overall time varisant below 200 kg cm provides the same positive results. The outcome will depend directly on the accuracy of the calculation of the preoperative correction performed and the quality of surgical achievement. Because of the need for precision, navigation technique appears as reliable, simple which makes it also possible to monitor the front slope and tibial rotation induced. The osteosynthesis must be stable and rigid to avoid postoperative loss of correction.


Asunto(s)
Articulación de la Rodilla/anomalías , Articulación de la Rodilla/cirugía , Osteoartritis de la Rodilla/cirugía , Osteotomía/métodos , Tibia/cirugía , Adulto , Anciano , Intervalos de Confianza , Femenino , Estudios de Seguimiento , Humanos , Articulación de la Rodilla/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias , Radiografía , Reoperación , Tibia/diagnóstico por imagen , Factores de Tiempo , Resultado del Tratamiento
3.
Rev Chir Orthop Reparatrice Appar Mot ; 93(4 Suppl): 2S55-8, 2007 Jun.
Artículo en Francés | MEDLINE | ID: mdl-17646830

RESUMEN

Mesenchymal stem cells (MSC) are progenitors of osteoblasts, chondrocytes and adipocytes. They are in the bone marrow at the concentration of 1 to 104 at 105 mononucleated cells. There is not specific marker to select them. They can be cultured and differentiated in osteoblats or chondrocytes. They induced osteoformation in autologous bone graft. Therapeutic application includes concentrate of bone marrow or MSC expanded by culture, implanted with or without biomaterials. The implantation of MSC cultured on biomaterial has not been yet published in human. The aim of these technics is to reduce the use of bone graft. The first indications for these technics will be pseudarthrosis and bone defect.


Asunto(s)
Células Madre Mesenquimatosas/fisiología , Osteogénesis , Investigación Biomédica , Humanos
4.
Rev Chir Orthop Reparatrice Appar Mot ; 93(4 Suppl): 2S33-46, 2007 Jun.
Artículo en Francés | MEDLINE | ID: mdl-17646827

RESUMEN

Pertrochanteric fractures constitute a major public health concern. This retrospective multicentric study evaluated outcome after treatment in patients aged over 75 years hospitalized for pertrochanteric fractures over a one year period (May 2004-May 2005). Five University Hospitals in the cities of Angers, Brest, Rennes, Tours, Nantes participated in this evaluation. The quality of the reduction and the position of the osteosynthesis were the two main criteria for good outcome. The type of material implanted had little effect on outcome. The results emphasized the importance of preventing osteoporosis. Fracture prevention and treatment of osteoporosis are crucial, even after fracture.


Asunto(s)
Fracturas de Cadera/cirugía , Anciano , Anciano de 80 o más Años , Árboles de Decisión , Femenino , Fracturas de Cadera/etiología , Humanos , Masculino , Osteoporosis/complicaciones , Osteoporosis/cirugía , Complicaciones Posoperatorias/etiología , Seudoartrosis/etiología , Estudios Retrospectivos , Insuficiencia del Tratamiento
5.
Cancer Radiother ; 10(6-7): 425-9, 2006 Nov.
Artículo en Francés | MEDLINE | ID: mdl-16928460

RESUMEN

The first step for treatment of bone metastases is to confirm the diagnosis, particularly if there is only one localisation, so as to exclude a primary bone tumour. Surgery and percutaneous injection of acrylic cement are both efficient to relieve pain. Their indications and timing have to be discussed in pluridisciplinary staff. Long bones metastases have to be nailed before pathologic fracture. If there is suspicion of hypervascularisation, the lesion has to be embolized before any procedure. Treatment of spinal metastases with neurological impairment is an emergency. Paraplegia may be a consequence within a few hours. They have to be treated in an orthopedic or neurosurgery department with the experience of posterior and anterior approach of the spine. Surveillance may be useful to diagnose these metastases before neurological impairment. Depending from the type of cancer, the chemo- and radiotherapy sensibility, the number of metastases, the condition of the posterior wall of the vertebra and the general condition of the patient, different surgical treatments may be possible going from complete resection of the lesion to percutaneous injection of acrylic cement. Conventional radiotherapy is associated to surgery. Satisfactory results of such treatments justify greater involvement of orthopaedic surgery team in multidisciplinary staff.


Asunto(s)
Cementos para Huesos , Neoplasias Óseas/secundario , Neoplasias Óseas/cirugía , Administración Cutánea , Humanos , Neoplasias de la Columna Vertebral/secundario , Neoplasias de la Columna Vertebral/cirugía , Columna Vertebral/cirugía
6.
Bone ; 37(1): 74-86, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15894525

RESUMEN

The efficacy of zoledronic acid (ZOL), with or without the anticancer drug ifosfamide (IFO), was tested on primary bone tumor growth using a rat-transplantable model of osteosarcoma. The effects on bone remodeling and tumor growth were analyzed by radiography, micro-computed tomography (micro-CT), and histological staining. The in vitro effects of ZOL were studied by proliferation, apoptosis, and cell cycle analyses on the osteosarcoma cells OSRGA compared to rat primary osteoblasts. Treatment with ZOL was effective in preventing the formation of osteolytic lesions that developed in bone sites and in reducing the local tumor growth, as compared to the untreated rats. The combination of ZOL and IFO was more effective than each agent alone in preventing tumor recurrence, improving tissue repair, and increasing bone formation as revealed by the analysis of trabecular architecture. In vitro studies demonstrated that ZOL was more potent against the OSRGA cell line than osteoblasts (with a half-maximal inhibitory effect on proliferation seen at 0.2 and 20 microM, respectively), the ZOL-induced inhibition of OSRGA proliferation being due to cell cycle arrest in S-phase. No effect on OSRGA apoptosis could be observed in vitro, as assessed by Hoechst staining and caspase-1 and -3 activation. In situ cell death was determined by TUNEL staining on tumor tissue sections. No significant difference in TUNEL-positive cells could be observed between ZOL-treated and -untreated rats. This is the first report of the anti-bone resorption and antitumoral activities of zoledronic acid in a rat model of osteosarcoma, and its beneficial association with an antitumoral chemotherapeutic drug in preventing tumor recurrence.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Osteosarcoma/tratamiento farmacológico , Animales , Remodelación Ósea/efectos de los fármacos , Caspasas/metabolismo , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Difosfonatos/administración & dosificación , Fibrosis , Ifosfamida/administración & dosificación , Imidazoles/administración & dosificación , Masculino , Necrosis , Metástasis de la Neoplasia/tratamiento farmacológico , Recurrencia Local de Neoplasia/tratamiento farmacológico , Osteoblastos/metabolismo , Osteogénesis/efectos de los fármacos , Osteosarcoma/mortalidad , Osteosarcoma/patología , Ratas , Ratas Sprague-Dawley , Fase S/efectos de los fármacos , Tasa de Supervivencia , Tibia/diagnóstico por imagen , Tibia/patología , Factores de Tiempo , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Ácido Zoledrónico
7.
Allerg Immunol (Paris) ; 28(4): 106, 109-11, 1996 Apr.
Artículo en Francés | MEDLINE | ID: mdl-8645420

RESUMEN

We present a comparative study of measurement of dog-epithelium-specific IgE by two Pharmacia CAP Rast techniques e2 and e5. For both measurements the technique is identical, but the allergen extracts are different: e2 = dachshund extract whilst e5 = a mixture of squames of german shepherd and poodle. We show that the e5-specific IgE seems to be more sensitive than the e2-specific IgE.


Asunto(s)
Alérgenos/inmunología , Inmunoglobulina E/análisis , Prueba de Radioalergoadsorción/métodos , Animales , Perros , Humanos , Pruebas Cutáneas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA